Skip to main content
OpenTrials

Clinical trial condition

Diabetic Nephropathies

Explore clinical trials studying Diabetic Nephropathies. Study availability and eligibility vary by location and protocol.

370 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Diabetic Nephropathies trial results

Completed

INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy

NCT00153088

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, +7 more
Locations
  • Boehringer Ingelheim Investigational Site Adachi-ku, Tokyo, Japan
  • Boehringer Ingelheim Investigational Site Amagasaki, Hyogo, Japan
  • Boehringer Ingelheim Investigational Site Arakawa-ku, Tokyo, Japan
  • Boehringer Ingelheim Investigational Site Asaguchi-gun, Okayama, Japan
View all 160 locations
View Trial Details
Completed

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

NCT01399580

Conditions
Chronic Disease, Chronic Kidney Disease, Diabetes Complications, +15 more
Locations
  • Site Reference ID/Investigator# 58144 Phoenix, Arizona, United States
  • Site Reference ID/Investigator# 71034 Tempe, Arizona, United States
  • Site Reference ID/Investigator# 56927 Azusa, California, United States
  • Site Reference ID/Investigator# 70793 Azusa, California, United States
View all 28 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

NCT01356849

Conditions
Chronic Disease, Chronic Kidney Disease, Diabetes Complications, +19 more
Locations
  • Site Reference ID/Investigator# 46345 Pell City, Alabama, United States
  • Site Reference ID/Investigator# 46035 Tempe, Arizona, United States
  • Site Reference ID/Investigator# 46016 Azusa, California, United States
  • Site Reference ID/Investigator# 45992 Chula Vista, California, United States
View all 72 locations
View Trial Details

Related conditions